
IMMUTEP Ltd — Investor Relations & Filings
Immutep Ltd. is a late clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune diseases. As a pioneer in its field, the company focuses on therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Immutep's diversified portfolio is designed to harness LAG-3 to either stimulate the immune response to fight cancer or modulate it to combat autoimmune diseases. Its lead product candidate is eftilagimod alfa, a soluble LAG-3 fusion protein under investigation in multiple oncology trials. The company maintains a pipeline of several clinical-stage assets targeting areas of high unmet medical need.
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 39615357 | 6-K - IMMUTEP Ltd (0001506184) (Filer) | 2026-05-01 | English | ||
|
2025
14 filings
| |||||
| 12405217 | 6-K | 2025-12-22 | English | ||
| 12405218 | 6-K | 2025-12-16 | English | ||
| 12405219 | FORM 6-K | 2025-12-09 | English | ||
| 12405220 | FORM 6-K | 2025-12-03 | English | ||
| 12405221 | FORM 6-K | 2025-11-14 | English | ||
| 12405223 | 6-K | 2025-11-04 | English | ||
| 12405222 | 6-K | 2025-10-30 | English | ||
| 12405224 | 20-F | 2025-10-24 | English | ||
| 12405225 | 6-K | 2025-10-21 | English | ||
| 12405228 | 6-K | 2025-10-21 | English | ||
| 12405226 | 6-K | 2025-10-14 | English | ||
| 12405227 | 6-K | 2025-10-09 | English | ||
| 12405231 | 6-K | 2025-09-23 | English | ||
| 12405229 | 6-K | 2025-09-03 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ovation Science Inc.
Develops and licenses patented Invisicare® technology for e…
|
OVAT | CA | Professional, scientific and te… |
|
OXFORD BIODYNAMICS PLC
Develops and commercializes precision medicine tests for on…
|
OBD | GB | Professional, scientific and te… |
|
Oxurion NV
Acquires majority stakes in European pharmaceutical subcont…
|
OXUR | BE | Professional, scientific and te… |
|
PACIFIC EDGE LIMITED
Develops non-invasive molecular tests for bladder cancer de…
|
PEB | NZ | Professional, scientific and te… |
|
PARADIGM BIOPHARMACEUTICALS LIMITED..
Repurposing PPS for osteoarthritis and rare inflammatory di…
|
PAR | AU | Professional, scientific and te… |
|
Pasithea Therapeutics Corp.
Develops treatments for central nervous system disorders, R…
|
KTTA | US | Professional, scientific and te… |
|
Passage BIO, Inc.
A clinical-stage genetic medicines company developing thera…
|
PASG | US | Professional, scientific and te… |
|
PATRYS LIMITED
Develops Deoxymab antibody therapies targeting DNA repair m…
|
PAB | AU | Professional, scientific and te… |
|
PAVmed Inc.
A diversified medical technology company developing devices…
|
PAVM | US | Professional, scientific and te… |
|
PegBio Co., Ltd.
Specializes in discovering and developing innovative therap…
|
2565 | HK | Professional, scientific and te… |
IMMUTEP Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33450/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33450 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33450 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33450 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33450}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMMUTEP Ltd (id: 33450)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.